Breaking News

GE to Invest €150mn in Biopharma Manufacturing

Plans to establish four prefabricated, off-the-shelf biologics factories for GE customers in GE BioPark Cork

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GE has unveiled plans to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s site at Loughbeg, Ringaskiddy, Co. Cork. GE BioPark Cork, subject to contract and planning approvals, will feature Europe’s first KUBio, prefabricated, off-the-shelf bio-manufacturing facilities, owned and run by GE customers, and will serve as focal point for further investment in next-generation biopharmaceutical manufacturing in Ireland. GE BioPark C...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters